These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29734307)

  • 1. Drug pipeline: 1Q18.
    DeFrancesco L
    Nat Biotechnol; 2018 May; 36(5):386. PubMed ID: 29734307
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug pipeline: 4Q17.
    DeFrancesco L
    Nat Biotechnol; 2018 Feb; 36(2):130. PubMed ID: 29406509
    [No Abstract]   [Full Text] [Related]  

  • 3. Ustekinumab poised to enter the psoriasis market.
    Schmidt C
    Nat Biotechnol; 2008 Dec; 26(12):1317-8. PubMed ID: 19060851
    [No Abstract]   [Full Text] [Related]  

  • 4. New drug for multidrug-resistant HIV.
    Nat Biotechnol; 2018 Apr; 36(4):291. PubMed ID: 29621221
    [No Abstract]   [Full Text] [Related]  

  • 5. COSENTYX (Secukinumab).
    Gupta AK; Foley KA; Abramovits W
    Skinmed; 2015; 13(4):303-6. PubMed ID: 26861430
    [No Abstract]   [Full Text] [Related]  

  • 6. Fast track for antiretroviral.
    AIDS Patient Care STDS; 2003 Dec; 17(12):665. PubMed ID: 14750222
    [No Abstract]   [Full Text] [Related]  

  • 7. Guselkumab: First Global Approval.
    Markham A
    Drugs; 2017 Sep; 77(13):1487-1492. PubMed ID: 28819723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New biologics in psoriasis: an update on IL-23 and IL-17 inhibitors.
    Dong J; Goldenberg G
    Cutis; 2017 Feb; 99(2):123-127. PubMed ID: 28319618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A piece of history.
    Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894179
    [No Abstract]   [Full Text] [Related]  

  • 10. Fresh from the biotech pipeline-2018.
    Morrison C
    Nat Biotechnol; 2019 Feb; 37(2):118-123. PubMed ID: 30718867
    [No Abstract]   [Full Text] [Related]  

  • 11. Promising gene therapies pose million-dollar conundrum.
    Check Hayden E
    Nature; 2016 Jun; 534(7607):305-6. PubMed ID: 27306167
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New plaque psoriasis approval carries suicide warning.
    Mullard A
    Nat Rev Drug Discov; 2017 Mar; 16(3):155. PubMed ID: 28248935
    [No Abstract]   [Full Text] [Related]  

  • 14. Living therapeutics: Scientists genetically modify bacteria to deliver drugs.
    Maxmen A
    Nat Med; 2017 Jan; 23(1):5-7. PubMed ID: 28060795
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel psoriasis therapies and patient outcomes, part 2: biologic treatments.
    Feely MA; Smith BL; Weinberg JM
    Cutis; 2015 May; 95(5):282-90. PubMed ID: 26057506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secukinumab (Cosentyx) for psoriasis.
    Med Lett Drugs Ther; 2015 Mar; 57(1465):45-7. PubMed ID: 25853578
    [No Abstract]   [Full Text] [Related]  

  • 17. Genentech and IDEC await approval of lymphoma Mab.
    Nat Biotechnol; 1997 Apr; 15(4):301. PubMed ID: 9094110
    [No Abstract]   [Full Text] [Related]  

  • 18. A sense of insecurity.
    Weinberg JM
    Cutis; 2009 Sep; 84(3):126. PubMed ID: 19842569
    [No Abstract]   [Full Text] [Related]  

  • 19. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
    Kaiser J
    Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
    [No Abstract]   [Full Text] [Related]  

  • 20. Off-label use of tumor necrosis factor inhibitors on ankylosing spondylitis, ulcerative colitis, and psoriasis.
    TEC Bull (Online); 2003 Jun; 20(2):9-18. PubMed ID: 12854551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.